Annual D&A
$1.89 M
-$14.00 K-0.74%
31 December 2023
Summary:
Compass Therapeutics annual depreciation & amortization is currently $1.89 million, with the most recent change of -$14.00 thousand (-0.74%) on 31 December 2023. During the last 3 years, it has fallen by -$514.00 thousand (-21.38%). CMPX annual D&A is now -21.38% below its all-time high of $2.40 million, reached on 01 December 2020.CMPX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$465.00 K
-$1000.00-0.21%
01 September 2024
Summary:
Compass Therapeutics quarterly depreciation & amortization is currently $465.00 thousand, with the most recent change of -$1000.00 (-0.21%) on 01 September 2024. Over the past year, it has dropped by -$1000.00 (-0.21%). CMPX quarterly D&A is now -56.50% below its all-time high of $1.07 million, reached on 01 December 2020.CMPX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$1.86 M
-$1000.00-0.05%
01 September 2024
Summary:
Compass Therapeutics TTM depreciation & amortization is currently $1.86 million, with the most recent change of -$1000.00 (-0.05%) on 01 September 2024. Over the past year, it has dropped by -$44.00 thousand (-2.31%). CMPX TTM D&A is now -22.55% below its all-time high of $2.40 million, reached on 01 December 2020.CMPX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CMPX Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.7% | -0.2% | -2.3% |
| 3 y3 years | -21.4% | +14.5% | -18.9% |
| 5 y5 years | -1.6% | - | - |
CMPX Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -21.4% | +16.4% | -6.6% | +17.4% | -18.9% | +14.7% |
| 5 y | 5 years | -21.4% | +16.4% | -56.5% | +17.4% | -22.6% | +302.2% |
| alltime | all time | -21.4% | +16.4% | -56.5% | +17.4% | -22.6% | +302.2% |
Compass Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $465.00 K(-0.2%) | $1.86 M(-0.1%) |
| June 2024 | - | $466.00 K(+0.6%) | $1.86 M(-0.5%) |
| Mar 2024 | - | $463.00 K(-1.1%) | $1.87 M(-1.0%) |
| Dec 2023 | $1.89 M(-0.7%) | $468.00 K(+0.4%) | $1.89 M(-0.8%) |
| Sept 2023 | - | $466.00 K(-1.9%) | $1.91 M(-1.1%) |
| June 2023 | - | $475.00 K(-1.2%) | $1.93 M(-1.2%) |
| Mar 2023 | - | $481.00 K(-0.6%) | $1.95 M(+2.4%) |
| Dec 2022 | $1.90 M(+17.2%) | $484.00 K(-0.6%) | $1.90 M(+4.8%) |
| Sept 2022 | - | $487.00 K(-2.2%) | $1.82 M(+4.7%) |
| June 2022 | - | $498.00 K(+14.5%) | $1.74 M(+5.4%) |
| Mar 2022 | - | $435.00 K | $1.65 M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $1.62 M(-32.4%) | - | - |
| Dec 2021 | - | $396.00 K(-2.5%) | $1.62 M(-29.3%) |
| Sept 2021 | - | $406.00 K(-0.7%) | $2.30 M(-1.2%) |
| June 2021 | - | $409.00 K(-1.0%) | $2.33 M(-1.2%) |
| Mar 2021 | - | $413.00 K(-61.4%) | $2.35 M(-2.1%) |
| Dec 2020 | $2.40 M(+13.4%) | $1.07 M(+145.7%) | $2.40 M(+80.1%) |
| Sept 2020 | - | $435.00 K(-0.5%) | $1.33 M(+48.3%) |
| June 2020 | - | $437.00 K(-5.6%) | $900.00 K(+94.4%) |
| Mar 2020 | - | $463.00 K | $463.00 K |
| Dec 2019 | $2.12 M(+10.4%) | - | - |
| Dec 2018 | $1.92 M | - | - |
FAQ
- What is Compass Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Compass Therapeutics?
- What is Compass Therapeutics annual D&A year-on-year change?
- What is Compass Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Compass Therapeutics?
- What is Compass Therapeutics quarterly D&A year-on-year change?
- What is Compass Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Compass Therapeutics?
- What is Compass Therapeutics TTM D&A year-on-year change?
What is Compass Therapeutics annual depreciation & amortization?
The current annual D&A of CMPX is $1.89 M
What is the all time high annual D&A for Compass Therapeutics?
Compass Therapeutics all-time high annual depreciation & amortization is $2.40 M
What is Compass Therapeutics annual D&A year-on-year change?
Over the past year, CMPX annual depreciation & amortization has changed by -$14.00 K (-0.74%)
What is Compass Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of CMPX is $465.00 K
What is the all time high quarterly D&A for Compass Therapeutics?
Compass Therapeutics all-time high quarterly depreciation & amortization is $1.07 M
What is Compass Therapeutics quarterly D&A year-on-year change?
Over the past year, CMPX quarterly depreciation & amortization has changed by -$1000.00 (-0.21%)
What is Compass Therapeutics TTM depreciation & amortization?
The current TTM D&A of CMPX is $1.86 M
What is the all time high TTM D&A for Compass Therapeutics?
Compass Therapeutics all-time high TTM depreciation & amortization is $2.40 M
What is Compass Therapeutics TTM D&A year-on-year change?
Over the past year, CMPX TTM depreciation & amortization has changed by -$44.00 K (-2.31%)